United States Generic Drug Industry 2016 Deep Market Research Report

1 Industry Overview

1.1 Definition and Specifications of Generic Drug

1.1.1 Definition of Generic Drug

1.1.2 Specifications of Generic Drug

1.2 Classification of Generic Drug

1.3 Applications of Generic Drug

1.4 Industry Chain Structure of Generic Drug

1.5 Industry Overview of Generic Drug

1.6 Industry Policy Analysis of Generic Drug

1.7 Industry News Analysis of Generic Drug

2 Manufacturing Cost Structure Analysis of Generic Drug

2.1 Bill of Materials (BOM) of Generic Drug

2.2 BOM Price Analysis of Generic Drug

2.3 Labor Cost Analysis of Generic Drug

2.4 Depreciation Cost Analysis of Generic Drug

2.5 Manufacturing Cost Structure Analysis of Generic Drug

2.6 Manufacturing Process Analysis of Generic Drug

2.7 United States Price, Cost and Gross of Generic Drug 2011-2016

3 Technical Data and Manufacturing Plants Analysis

3.1 Capacity and Commercial Production Date of United States Key Manufacturers in 2015

3.2 Manufacturing Plants Distribution of United States Key Generic Drug Manufacturers in 2015

3.3 R&D Status and Technology Source of United States Generic Drug Key Manufacturers in 2015

3.4 Raw Materials Sources Analysis of United States Generic Drug Key Manufacturers in 2015

4 Production Analysis of Generic Drug by Regions, Type, and Applications

4.1 United States Production of Generic Drug by Regions 2011-2016

4.2 United States Production of Generic Drug by Type 2011-2016

4.3 United States Sales of Generic Drug by Applications 2011-2016

4.4 Price Analysis of United States Generic Drug Key Manufacturers in 2015

4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Generic Drug 2011-2016

5 Consumption Volume and Consumption Value Analysis of Generic Drug by Regions

5.1 United States Consumption Volume of Generic Drug by Regions 2011-2016

5.2 United States Consumption Value of Generic Drug by Regions 2011-2016

5.3 United States Consumption Price Analysis of Generic Drug by Regions 2011-2016

6 Analysis of Generic Drug Production, Supply, Sales and Market Status 2011-2016

6.1 Capacity, Production, Sales, and Revenue of Generic Drug 2011-2016

6.2 Production Market Share and Sales Market Share Analysis of Generic Drug 2014-2015

6.3 Sales Overview of Generic Drug 2011-2016

6.4 Supply, Consumption and Gap of Generic Drug 2011-2016

6.5 Import, Export and Consumption of Generic Drug 2011-2016

6.6 Cost, Price, Revenue and Gross Margin of Generic Drug 2011-2016

7 Analysis of Generic Drug Industry Key Manufacturers

7.1 Teva Pharmaceuticals

7.1.1 Company Profile

7.1.2 Product Picture and Specifications

7.1.2.1 Type I

7.1.2.2 Type II

7.1.2.3 Type III

7.1.3 Capacity, Production, Price, Cost, Gross and Revenue

7.1.4 Contact Information

7.2 Sandoz

7.2.1 Company Profile

7.2.2 Product Picture and Specifications

7.2.2.1 Type I

7.2.2.2 Type II

7.2.2.3 Type III

7.2.3 Capacity, Production, Price, Cost, Gross and Revenue

7.2.4 Contact Information

7.3 Allergan

7.3.1 Company Profile

7.3.2 Product Picture and Specifications

7.3.2.1 Type I

7.3.2.2 Type II

7.3.2.3 Type III

7.3.3 Capacity, Production, Price, Cost, Gross and Revenue

7.3.4 Contact Information

7.4 Mylan

7.4.1 Company Profile

7.4.2 Product Picture and Specifications

7.4.2.1 Type I

7.4.2.2 Type II

7.4.2.3 Type III

7.4.3 Capacity, Production, Price, Cost, Gross and Revenue

7.4.4 Contact Information

7.5 Sun Pharmaceuticals

7.5.1 Company Profile

7.5.2 Product Picture and Specifications

7.5.2.1 Type I

7.5.2.2 Type II

7.5.2.3 Type III

7.5.3 Capacity, Production, Price, Cost, Gross and Revenue

7.5.4 Contact Information

7.6 STADA Arzneimittel

7.6.1 Company Profile

7.6.2 Product Picture and Specifications

7.6.2.1 Type I

7.6.2.2 Type II

7.6.2.3 Type III

7.6.3 Capacity, Production, Price, Cost, Gross and Revenue

7.6.4 Contact Information

7.7 Abbott

7.7.1 Company Profile

7.7.2 Product Picture and Specifications

7.7.2.1 Type I

7.7.2.2 Type II

7.7.2.3 Type III

7.7.3 Capacity, Production, Price, Cost, Gross and Revenue

7.7.4 Contact Information

7.8 Baxter

7.8.1 Company Profile

7.8.2 Product Picture and Specifications

7.8.2.1 Type I

7.8.2.2 Type II

7.8.2.3 Type III

7.8.3 Capacity, Production, Price, Cost, Gross and Revenue

7.8.4 Contact Information

7.9 Boehringer Ingelheim

7.9.1 Company Profile

7.9.2 Product Picture and Specifications

7.9.2.1 Type I

7.9.2.2 Type II

7.9.2.3 Type III

7.9.3 Capacity, Production, Price, Cost, Gross and Revenue

7.9.4 Contact Information

7.10 Daiichi Sankyo

7.10.1 Company Profile

7.10.2 Product Picture and Specifications

7.10.2.1 Type I

7.10.2.2 Type II

7.10.2.3 Type III

7.10.3 Capacity, Production, Price, Cost, Gross and Revenue

7.10.4 Contact Information

7.11 Eli Lilly

7.11.1 Company Profile

7.11.2 Product Picture and Specifications

7.11.2.1 Type I

7.11.2.2 Type II

7.11.2.3 Type III

7.11.3 Capacity, Production, Price, Cost, Gross and Revenue

7.11.4 Contact Information

7.12 GlaxoSmithKline

7.12.1 Company Profile

7.12.2 Product Picture and Specifications

7.12.2.1 Type I

7.12.2.2 Type II

7.12.2.3 Type III

7.12.3 Capacity, Production, Price, Cost, Gross and Revenue

7.12.4 Contact Information

7.13 Mitsubishi Tanabe Pharma

7.13.1 Company Profile

7.13.2 Product Picture and Specifications

7.13.2.1 Type I

7.13.2.2 Type II

7.13.2.3 Type III

7.13.3 Capacity, Production, Price, Cost, Gross and Revenue

7.13.4 Contact Information

7.14 Pfizer

7.14.1 Company Profile

7.14.2 Product Picture and Specifications

7.14.2.1 Type I

7.14.2.2 Type II

7.14.2.3 Type III

7.14.3 Capacity, Production, Price, Cost, Gross and Revenue

7.14.4 Contact Information

7.15 Roche

7.15.1 Company Profile

7.15.2 Product Picture and Specifications

7.15.2.1 Type I

7.15.2.2 Type II

7.15.2.3 Type III

7.15.3 Capacity, Production, Price, Cost, Gross and Revenue

7.15.4 Contact Information

7.16 Sanofi

7.16.1 Company Profile

7.16.2 Product Picture and Specifications

7.16.2.1 Type I

7.16.2.2 Type II

7.16.2.3 Type III

7.16.3 Capacity, Production, Price, Cost, Gross and Revenue

7.16.4 Contact Information

8 Price and Gross Margin Analysis

8.1 Analysis of Price

8.2 Gross Margin Analysis

8.3 Price Comparison by Regions

8.4 Price Analysis of Different Generic Drug Product Types

8.5 Market Share Analysis of Different Generic Drug Price Levels

8.6 Gross Margin Analysis of Different Generic Drug Applications

9 Marketing Trader or Distributor Analysis of Generic Drug

9.1 Marketing Channels Status of Generic Drug

9.2 Traders or Distributors of Generic Drug with Contact Information

9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Generic Drug

9.4 United States Import, Export and Trade Analysis of Generic Drug

10 Development Trend of Generic Drug Industry 2016-2021

10.1 Capacity and Production Overview of Generic Drug 2016-2021

10.2 Production Market Share by Product Types of Generic Drug 2016-2021

10.3 Sales and Sales Revenue Overview of Generic Drug 2016-2021

10.4 United States Sales of Generic Drug by Applications 2016-2021

10.5 Import, Export and Consumption of Generic Drug 2016-2021

10.6 Cost, Price, Revenue and Gross Margin of Generic Drug 2016-2021

11 Industry Chain Suppliers of Generic Drug with Contact Information

11.1 Major Raw Materials Suppliers of Generic Drug with Contact Information

11.2 Manufacturing Equipment Suppliers of Generic Drug with Contact Information

11.3 Major Players of Generic Drug with Contact Information

11.4 Key Consumers of Generic Drug with Contact Information

11.5 Supply Chain Relationship Analysis of Generic Drug

12 New Project Investment Feasibility Analysis of Generic Drug

12.1 New Project SWOT Analysis of Generic Drug

12.2 New Project Investment Feasibility Analysis of Generic Drug

13 Conclusion of the United States Generic Drug Industry 2016 Market Research Report

Figure Picture of Generic Drug

Table Product Specifications of Generic Drug

Table Classification of Generic Drug

Figure United States Sales Market Share of Generic Drug by Product Types in 2015

Table Applications of Generic Drug

Figure United States Sales Market Share of Generic Drug by Applications in 2015

Figure Industry Chain Structure of Generic Drug

Table United States Industry Overview of Generic Drug

Table Industry Policy of Generic Drug

Table Industry News List of Generic Drug

Table Bill of Materials (BOM) of Generic Drug

Table Bill of Materials (BOM) Price of Generic Drug

Table Labor Cost of Generic Drug

Table Depreciation Cost of Generic Drug

Table Manufacturing Cost Structure Analysis of Generic Drug in 2015

Figure Manufacturing Process Analysis of Generic Drug

Table United States Price Analysis of Generic Drug 2011-2016 (USD/Dose)

Table United States Cost Analysis of Generic Drug 2011-2016 (USD/Dose)

Table United States Gross Analysis of Generic Drug 2011-2016

Table Capacity (K Doses) and Commercial Production Date of United States Generic Drug Key Manufacturers in 2015

Table Manufacturing Plants Distribution of United States Key Generic Drug Manufacturers in 2015

Table R&D Status and Technology Source of United States Generic Drug Key Manufacturers in 2015

Table Raw Materials Sources Analysis of United States and United States Generic Drug Key Manufacturers in 2015

Table United States Production of Generic Drug by Regions 2011-2016 (K Doses)

Table United States Production Market Share of Generic Drug by Regions 2011-2016

Figure United States Production Market Share of Generic Drug by Regions in 2014

Figure United States Production Market Share of Generic Drug by Regions in 2015

Table United States Production of Generic Drug by Types in 2011-2016 (K Doses)

Table United States Production Market Share of Generic Drug by Type in 2011-2016

Figure United States Production Market Share of Generic Drug by Type in 2014

Figure United States Production Market Share of Generic Drug by Type in 2015

Table United States Sales of Generic Drug by Applications 2011-2016 (K Doses)

Table United States Production Market Share of Generic Drug by Applications 2011-2016

Figure United States Production Market Share of Generic Drug by Applications in 2014

Figure United States Production Market Share of Generic Drug by Applications in 2015

Table Price Comparison of United States Generic Drug Key Manufacturers in 2015 (USD/Dose)

Table United States Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Generic Drug 2011-2016

Table United States Consumption Volume of Generic Drug by Regions 2011-2016 (K Doses)

Table United States Consumption Volume Market Share of Generic Drug by Regions 2011-2016

Figure United States Consumption Volume Market Share of Generic Drug by Regions in 2014

Figure United States Consumption Volume Market Share of Generic Drug by Regions in 2015

Table United States Consumption Value of Generic Drug by Regions 2011-2016 (M USD)

Table United States Consumption Value Market Share of Generic Drug by Regions 2011-2016

Figure United States Consumption Value Market Share of Generic Drug by Regions in 2014

Figure United States Consumption Value Market Share of Generic Drug by Regions in 2015

Table Consumption Price of Generic Drug by Regions 2011-2016 (USD/Dose)

Table United States and Major Manufacturers Capacity of Generic Drug 2011-2016 (K Doses)

Table United States Capacity Market Share of Major Generic Drug Manufacturers 2011-2016

Table United States and Major Manufacturers Production of Generic Drug 2011-2016 (K Doses)

Table United States Production Market Share of Major Generic Drug Manufacturers 2011-2016

Table United States and Major Manufacturers Sales of Generic Drug 2011-2016 (K Doses)

Table United States Sales Market Share of Major Generic Drug Manufacturers 2011-2016

Table United States and Major Manufacturers Sales Revenue of Generic Drug 2011-2016 (M USD)

Table United States Sales Revenue Market Share of Major Generic Drug Manufacturers 2011-2016

Figure United States Capacity (K Doses), Production (K Doses) and Growth Rate of Generic Drug 2011-2016

Figure United States Capacity Utilization Rate of Generic Drug 2011-2016

Figure United States Sales Revenue (M USD) and Growth Rate of Generic Drug 2011-2016

Figure United States Production Market Share of Major Generic Drug Manufacturers in 2014

Figure United States Production Market Share of Major Generic Drug Manufacturers in 2015

Figure United States Sales Market Share of Major Generic Drug Manufacturers in 2014

Figure United States Sales Market Share of Major Generic Drug Manufacturers in 2015

Figure United States Sales (K Doses) and Growth Rate of Generic Drug 2011-2016

Table United States Supply, Consumption and Gap of Generic Drug 2011-2016 (K Doses)

Table United States Import, Export and Consumption of Generic Drug 2011-2016 (K Doses)

Table Price of United States Generic Drug Major Manufacturers 2011-2016 (USD/Dose)

Table Gross Margin of United States Generic Drug Major Manufacturers 2011-2016

Table United States and Major Manufacturers Revenue of Generic Drug 2011-2016 (M USD)

Table United States Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Generic Drug 2011-2016

Table Teva Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Generic Drug Picture and Specifications of Teva Pharmaceuticals

Table Generic Drug Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Teva Pharmaceuticals 2011-2016

Figure Generic Drug Capacity (K Doses), Production (K Doses) and Growth Rate of Teva Pharmaceuticals 2011-2016

Figure Generic Drug Production (K Doses) and United States Market Share of Teva Pharmaceuticals 2011-2016

Table Teva Pharmaceuticals Generic Drug SWOT Analysis

Table Sandoz Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Generic Drug Picture and Specifications of Sandoz

Table Generic Drug Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Sandoz 2011-2016

Figure Generic Drug Capacity (K Doses), Production (K Doses) and Growth Rate of Sandoz 2011-2016

Figure Generic Drug Production (K Doses) and United States Market Share of Sandoz 2011-2016

Table Sandoz Generic Drug SWOT Analysis

Table Allergan Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Generic Drug Picture and Specifications of Allergan

Table Generic Drug Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Allergan 2011-2016

Figure Generic Drug Capacity (K Doses), Production (K Doses) and Growth Rate of Allergan 2011-2016

Figure Generic Drug Production (K Doses) and United States Market Share of Allergan 2011-2016

Table Allergan Generic Drug SWOT Analysis

Table Mylan Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Generic Drug Picture and Specifications of Mylan

Table Generic Drug Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Mylan 2011-2016

Figure Generic Drug Capacity (K Doses), Production (K Doses) and Growth Rate of Mylan 2011-2016

Figure Generic Drug Production (K Doses) and United States Market Share of Mylan 2011-2016

Table Mylan Generic Drug SWOT Analysis

Table Sun Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Generic Drug Picture and Specifications of Sun Pharmaceuticals

Table Generic Drug Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Sun Pharmaceuticals 2011-2016

Figure Generic Drug Capacity (K Doses), Production (K Doses) and Growth Rate of Sun Pharmaceuticals 2011-2016

Figure Generic Drug Production (K Doses) and United States Market Share of Sun Pharmaceuticals 2011-2016

Table Sun Pharmaceuticals Generic Drug SWOT Analysis

Table STADA Arzneimittel Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Generic Drug Picture and Specifications of STADA Arzneimittel

Table Generic Drug Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of STADA Arzneimittel 2011-2016

Figure Generic Drug Capacity (K Doses), Production (K Doses) and Growth Rate of STADA Arzneimittel 2011-2016

Figure Generic Drug Production (K Doses) and United States Market Share of STADA Arzneimittel 2011-2016

Table STADA Arzneimittel Generic Drug SWOT Analysis

Table Abbott Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Generic Drug Picture and Specifications of Abbott

Table Generic Drug Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Abbott 2011-2016

Figure Generic Drug Capacity (K Doses), Production (K Doses) and Growth Rate of Abbott 2011-2016

Figure Generic Drug Production (K Doses) and United States Market Share of Abbott 2011-2016

Table Abbott Generic Drug SWOT Analysis

Table Baxter Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Generic Drug Picture and Specifications of Baxter

Table Generic Drug Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Baxter 2011-2016

Figure Generic Drug Capacity (K Doses), Production (K Doses) and Growth Rate of Baxter 2011-2016

Figure Generic Drug Production (K Doses) and United States Market Share of Baxter 2011-2016

Table Baxter Generic Drug SWOT Analysis

Table Boehringer Ingelheim Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Generic Drug Picture and Specifications of Boehringer Ingelheim

Table Generic Drug Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Boehringer Ingelheim 2011-2016

Figure Generic Drug Capacity (K Doses), Production (K Doses) and Growth Rate of Boehringer Ingelheim 2011-2016

Figure Generic Drug Production (K Doses) and United States Market Share of Boehringer Ingelheim 2011-2016

Table Boehringer Ingelheim Generic Drug SWOT Analysis

Table Daiichi Sankyo Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Generic Drug Picture and Specifications of Daiichi Sankyo

Table Generic Drug Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Daiichi Sankyo 2011-2016

Figure Generic Drug Capacity (K Doses), Production (K Doses) and Growth Rate of Daiichi Sankyo 2011-2016

Figure Generic Drug Production (K Doses) and United States Market Share of Daiichi Sankyo 2011-2016

Table Daiichi Sankyo Generic Drug SWOT Analysis

Table Eli Lilly Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Generic Drug Picture and Specifications of Eli Lilly

Table Generic Drug Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Eli Lilly 2011-2016

Figure Generic Drug Capacity (K Doses), Production (K Doses) and Growth Rate of Eli Lilly 2011-2016

Figure Generic Drug Production (K Doses) and United States Market Share of Eli Lilly 2011-2016

Table Eli Lilly Generic Drug SWOT Analysis

Table GlaxoSmithKline Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Generic Drug Picture and Specifications of GlaxoSmithKline

Table Generic Drug Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of GlaxoSmithKline 2011-2016

Figure Generic Drug Capacity (K Doses), Production (K Doses) and Growth Rate of GlaxoSmithKline 2011-2016

Figure Generic Drug Production (K Doses) and United States Market Share of GlaxoSmithKline 2011-2016

Table GlaxoSmithKline Generic Drug SWOT Analysis

Table Mitsubishi Tanabe Pharma Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Generic Drug Picture and Specifications of Mitsubishi Tanabe Pharma

Table Generic Drug Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Mitsubishi Tanabe Pharma 2011-2016

Figure Generic Drug Capacity (K Doses), Production (K Doses) and Growth Rate of Mitsubishi Tanabe Pharma 2011-2016

Figure Generic Drug Production (K Doses) and United States Market Share of Mitsubishi Tanabe Pharma 2011-2016

Table Mitsubishi Tanabe Pharma Generic Drug SWOT Analysis

Table Pfizer Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Generic Drug Picture and Specifications of Pfizer

Table Generic Drug Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Pfizer 2011-2016

Figure Generic Drug Capacity (K Doses), Production (K Doses) and Growth Rate of Pfizer 2011-2016

Figure Generic Drug Production (K Doses) and United States Market Share of Pfizer 2011-2016

Table Pfizer Generic Drug SWOT Analysis

Table Roche Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Generic Drug Picture and Specifications of Roche

Table Generic Drug Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Roche 2011-2016

Figure Generic Drug Capacity (K Doses), Production (K Doses) and Growth Rate of Roche 2011-2016

Figure Generic Drug Production (K Doses) and United States Market Share of Roche 2011-2016

Table Roche Generic Drug SWOT Analysis

Table Sanofi Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Generic Drug Picture and Specifications of Sanofi

Table Generic Drug Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Sanofi 2011-2016

Figure Generic Drug Capacity (K Doses), Production (K Doses) and Growth Rate of Sanofi 2011-2016

Figure Generic Drug Production (K Doses) and United States Market Share of Sanofi 2011-2016

Table Sanofi Generic Drug SWOT Analysis

Table Generic Drug Price by Regions 2011-2016

Table Generic Drug Price by Product Types 2011-2016

Table Generic Drug Price by Companies 2011-2016

Table Generic Drug Gross Margin by Companies 2011-2016

Table Price Comparison of Generic Drug by Regions 2011-2016 (USD/Dose)

Table Price of Different Generic Drug Product Types (USD/Dose)

Table Market Share of Different Generic Drug Price Level

Table Gross Margin of Different Generic Drug Applications

Table Marketing Channels Status of Generic Drug

Table Traders or Distributors of Generic Drug with Contact Information

Table Ex-work Price, Channel Price and End Buyer Price of Generic Drug (USD/Dose) in 2015

Table United States Import, Export, and Trade of Generic Drug (K Doses)

Figure United States Capacity (K Doses), Production (K Doses) and Growth Rate of Generic Drug 2016-2021

Figure United States Capacity Utilization Rate of Generic Drug 2016-2021

Table United States Generic Drug Production by Type 2016-2021 (K Doses)

Table United States Generic Drug Production Market Share by Type 2016-2021

Figure United States Production Market Share of Generic Drug by Type in 2021

Figure United States Sales (K Doses) and Growth Rate of Generic Drug 2016-2021

Figure United States Sales Revenue (Million USD) and Growth Rate of Generic Drug 2016-2021

Figure United States Sales of Generic Drug by Applications 2016-2021 (K Doses)

Table United States Production Market Share of Generic Drug by Applications 2016-2021

Figure United States Production Market Share of Generic Drug by Applications in 2021

Table United States Production, Import, Export and Consumption of Generic Drug 2016-2021 (K Doses)

Table United States Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Generic Drug 2016-2021

Table Major Raw Materials Suppliers of Generic Drug with Contact Information

Table Manufacturing Equipment Suppliers of Generic Drug with Contact Information

Table Major Players of Generic Drug with Contact Information

Table Key Consumers of Generic Drug with Contact Information

Table Supply Chain Relationship Analysis of Generic Drug

Table New Project SWOT Analysis of Generic Drug

Table New Project Investment Feasibility Analysis of Generic Drug

Table Part of Interviewees Record List